dc.contributor.author | Tuncel, Murat | |
dc.date.accessioned | 2019-12-10T11:30:38Z | |
dc.date.available | 2019-12-10T11:30:38Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 2146-1414 | |
dc.identifier.uri | https://doi.org/10.4274/2017.26.suppl.10 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283706/ | |
dc.identifier.uri | http://hdl.handle.net/11655/15791 | |
dc.description.abstract | Thyroid stimulating hormone receptor (TSHR) plays a pivotal role in thyroid hormone metabolism. It is a major controller of thyroid cell function and growth. Mutations in TSHR may lead to several thyroid diseases, most commonly hyperthyroidism. Although its genetic and epigenetic alterations do not directly lead to carcinogenesis, it has a crucial role in tumor growth, which is initiated by several oncogenes. This article will provide a brief review of TSHR and related diseases. | |
dc.relation.isversionof | 10.4274/2017.26.suppl.10 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Thyroid Stimulating Hormone Receptor | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Molecular Imaging and Radionuclide Therapy | |
dc.contributor.department | Nükleer Tıp | |
dc.identifier.volume | 26 | |
dc.identifier.issue | Suppl 1 | |
dc.identifier.startpage | 87 | |
dc.identifier.endpage | 91 | |
dc.description.index | PubMed | |
dc.description.index | Scopus | |